-
1
-
-
0037452544
-
Fabry disease, an under-recognized multisystemic disorder: Expert recommendations for diagnosis, management, and enzyme replacement therapy
-
R.J. Desnick, R. Brady, J. Barranger, A.J. Collins, D.P. Germain, M. Goldman, G. Grabowski, S. Packman, and W.R. Wilcox Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy Ann Intern Med 138 2003 338 346
-
(2003)
Ann Intern Med
, vol.138
, pp. 338-346
-
-
Desnick, R.J.1
Brady, R.2
Barranger, J.3
Collins, A.J.4
Germain, D.P.5
Goldman, M.6
Grabowski, G.7
Packman, S.8
Wilcox, W.R.9
-
2
-
-
0344430257
-
Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium
-
J.C. Moon, B. Sachdev, A.G. Elkington, W.J. McKenna, A. Mehta, D.J. Pennell, P.J. Leed, and P.M. Elliott Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium Eur Heart J 24 2003 2151 2155
-
(2003)
Eur Heart J
, vol.24
, pp. 2151-2155
-
-
Moon, J.C.1
Sachdev, B.2
Elkington, A.G.3
McKenna, W.J.4
Mehta, A.5
Pennell, D.J.6
Leed, P.J.7
Elliott, P.M.8
-
3
-
-
68049129847
-
Natural course of Fabry disease: Changing pattern of causes of death in FOS - Fabry Outcome Survey
-
A. Mehta, J.T. Clarke, R. Giugliani, P. Elliott, A. Linhart, M. Beck, and G. Sunder-Plassmann Natural course of Fabry disease: changing pattern of causes of death in FOS - Fabry Outcome Survey J Med Genet 46 2009 548 552
-
(2009)
J Med Genet
, vol.46
, pp. 548-552
-
-
Mehta, A.1
Clarke, J.T.2
Giugliani, R.3
Elliott, P.4
Linhart, A.5
Beck, M.6
Sunder-Plassmann, G.7
-
4
-
-
73849102063
-
Life expectancy and cause of death in males and females with Fabry disease: Findings from the Fabry Registry
-
S. Waldek, M.R. Patel, M. Banikazemi, R. Lemay, and P. Lee Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry Genet Med 11 2009 790 796
-
(2009)
Genet Med
, vol.11
, pp. 790-796
-
-
Waldek, S.1
Patel, M.R.2
Banikazemi, M.3
Lemay, R.4
Lee, P.5
-
5
-
-
33745883269
-
The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease
-
J.C. Moon, M. Sheppard, E. Reed, P. Lee, P.M. Elliott, and D.J. Pennell The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease J Cardiovasc Magn Reson 8 2006 479 482
-
(2006)
J Cardiovasc Magn Reson
, vol.8
, pp. 479-482
-
-
Moon, J.C.1
Sheppard, M.2
Reed, E.3
Lee, P.4
Elliott, P.M.5
Pennell, D.J.6
-
6
-
-
20844452038
-
The variation of morphological and functional cardiac manifestation in Fabry disease: Potential implications for the time course of the disease
-
F. Weidemann, F. Breunig, M. Beer, J. Sandstede, S. Stork, W. Voelker, G. Ertl, A. Knoll, C. Wanner, and J.M. Strotmann The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease Eur Heart J 26 2005 1221 1227
-
(2005)
Eur Heart J
, vol.26
, pp. 1221-1227
-
-
Weidemann, F.1
Breunig, F.2
Beer, M.3
Sandstede, J.4
Stork, S.5
Voelker, W.6
Ertl, G.7
Knoll, A.8
Wanner, C.9
Strotmann, J.M.10
-
7
-
-
37149013595
-
A new echocardiographic approach for the detection of non-ischaemic fibrosis in hypertrophic myocardium
-
F. Weidemann, M. Niemann, S. Herrmann, M. Kung, S. Stork, C. Waller, M. Beer, F. Breunig, C. Wanner, W. Voelker, G. Ertl, B. Bijnens, and J.M. Strotmann A new echocardiographic approach for the detection of non-ischaemic fibrosis in hypertrophic myocardium Eur Heart J 28 2007 3020 3026
-
(2007)
Eur Heart J
, vol.28
, pp. 3020-3026
-
-
Weidemann, F.1
Niemann, M.2
Herrmann, S.3
Kung, M.4
Stork, S.5
Waller, C.6
Beer, M.7
Breunig, F.8
Wanner, C.9
Voelker, W.10
Ertl, G.11
Bijnens, B.12
Strotmann, J.M.13
-
8
-
-
84926203787
-
Relation of burden of myocardial fibrosis to malignant ventricular arrhythmias and outcomes in Fabry disease
-
J. Kramer, M. Niemann, S. Stork, S. Frantz, M. Beer, G. Ertl, C. Wanner, and F. Weidemann Relation of burden of myocardial fibrosis to malignant ventricular arrhythmias and outcomes in Fabry disease Am J Cardiol 114 2014 895 900
-
(2014)
Am J Cardiol
, vol.114
, pp. 895-900
-
-
Kramer, J.1
Niemann, M.2
Stork, S.3
Frantz, S.4
Beer, M.5
Ertl, G.6
Wanner, C.7
Weidemann, F.8
-
9
-
-
33748746594
-
Fabry disease: Guidelines for the evaluation and management of multi-organ system involvement
-
C.M. Eng, D.P. Germain, M. Banikazemi, D.G. Warnock, C. Wanner, R.J. Hopkin, J. Bultas, P. Lee, K. Sims, S.E. Brodie, G.M. Pastores, J.M. Strotmann, and W.R. Wilcox Fabry disease: guidelines for the evaluation and management of multi-organ system involvement Genet Med 8 2006 539 548
-
(2006)
Genet Med
, vol.8
, pp. 539-548
-
-
Eng, C.M.1
Germain, D.P.2
Banikazemi, M.3
Warnock, D.G.4
Wanner, C.5
Hopkin, R.J.6
Bultas, J.7
Lee, P.8
Sims, K.9
Brodie, S.E.10
Pastores, G.M.11
Strotmann, J.M.12
Wilcox, W.R.13
-
10
-
-
77951896083
-
Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation: Results of the XPECT trial
-
G. Hindricks, E. Pokushalov, L. Urban, M. Taborsky, K.H. Kuck, D. Lebedev, G. Rieger, and H. Purerfellner Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation: results of the XPECT trial Circ Arrhythm Electrophysiol 3 2010 141 147
-
(2010)
Circ Arrhythm Electrophysiol
, vol.3
, pp. 141-147
-
-
Hindricks, G.1
Pokushalov, E.2
Urban, L.3
Taborsky, M.4
Kuck, K.H.5
Lebedev, D.6
Rieger, G.7
Purerfellner, H.8
-
11
-
-
84916925479
-
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Heart Rhythm Society
-
C.T. January, L.S. Wann, J.S. Alpert, H. Calkins, J.E. Cigarroa, J.C. Cleveland Jr., J.B. Conti, P.T. Ellinor, M.D. Ezekowitz, M.E. Field, K.T. Murray, R.L. Sacco, W.G. Stevenson, P.J. Tchou, C.M. Tracy, and C.W. Yancy 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Heart Rhythm Society Circulation 130 2014 e199 e267
-
(2014)
Circulation
, vol.130
, pp. e199-e267
-
-
January, C.T.1
Wann, L.S.2
Alpert, J.S.3
Calkins, H.4
Cigarroa, J.E.5
Cleveland, J.C.6
Conti, J.B.7
Ellinor, P.T.8
Ezekowitz, M.D.9
Field, M.E.10
Murray, K.T.11
Sacco, R.L.12
Stevenson, W.G.13
Tchou, P.J.14
Tracy, C.M.15
Yancy, C.W.16
-
12
-
-
84872679424
-
2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the Heart Rhythm Society
-
A.E. Epstein, J.P. DiMarco, K.A. Ellenbogen, N.A. Estes 3rd, R.A. Freedman, L.S. Gettes, A.M. Gillinov, G. Gregoratos, S.C. Hammill, D.L. Hayes, M.A. Hlatky, L.K. Newby, R.L. Page, M.H. Schoenfeld, M.J. Silka, L.W. Stevenson, and M.O. Sweeney 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the Heart Rhythm Society Circulation 127 2013 e283 e352
-
(2013)
Circulation
, vol.127
, pp. e283-e352
-
-
Epstein, A.E.1
DiMarco, J.P.2
Ellenbogen, K.A.3
Estes, N.A.4
Freedman, R.A.5
Gettes, L.S.6
Gillinov, A.M.7
Gregoratos, G.8
Hammill, S.C.9
Hayes, D.L.10
Hlatky, M.A.11
Newby, L.K.12
Page, R.L.13
Schoenfeld, M.H.14
Silka, M.J.15
Stevenson, L.W.16
Sweeney, M.O.17
-
13
-
-
24944513802
-
Prevalence and clinical significance of cardiac arrhythmia in Anderson-Fabry disease
-
J.S. Shah, D.A. Hughes, B. Sachdev, M. Tome, D. Ward, P. Lee, A.B. Mehta, and P.M. Elliott Prevalence and clinical significance of cardiac arrhythmia in Anderson-Fabry disease Am J Cardiol 96 2005 842 846
-
(2005)
Am J Cardiol
, vol.96
, pp. 842-846
-
-
Shah, J.S.1
Hughes, D.A.2
Sachdev, B.3
Tome, M.4
Ward, D.5
Lee, P.6
Mehta, A.B.7
Elliott, P.M.8
-
14
-
-
79958810192
-
Differences in Fabry cardiomyopathy between female and male patients: Consequences for diagnostic assessment
-
M. Niemann, S. Herrmann, K. Hu, F. Breunig, J. Strotmann, M. Beer, W. Machann, W. Voelker, G. Ertl, C. Wanner, and F. Weidemann Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment JACC Cardiovasc Imaging 4 2011 592 601
-
(2011)
JACC Cardiovasc Imaging
, vol.4
, pp. 592-601
-
-
Niemann, M.1
Herrmann, S.2
Hu, K.3
Breunig, F.4
Strotmann, J.5
Beer, M.6
Machann, W.7
Voelker, W.8
Ertl, G.9
Wanner, C.10
Weidemann, F.11
-
15
-
-
84925156343
-
The Fabry cardiomyopathy - Diagnostic approach and current treatment
-
F. Weidemann, G. Ertl, C. Wanner, and J. Kramer The Fabry cardiomyopathy - diagnostic approach and current treatment Curr Pharm Des 21 2015 473 478
-
(2015)
Curr Pharm des
, vol.21
, pp. 473-478
-
-
Weidemann, F.1
Ertl, G.2
Wanner, C.3
Kramer, J.4
-
16
-
-
61349177862
-
Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: Evidence for a better outcome with early treatment
-
F. Weidemann, M. Niemann, F. Breunig, S. Herrmann, M. Beer, S. Stork, W. Voelker, G. Ertl, C. Wanner, and J. Strotmann Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment Circulation 119 2009 524 529
-
(2009)
Circulation
, vol.119
, pp. 524-529
-
-
Weidemann, F.1
Niemann, M.2
Breunig, F.3
Herrmann, S.4
Beer, M.5
Stork, S.6
Voelker, W.7
Ertl, G.8
Wanner, C.9
Strotmann, J.10
-
17
-
-
84919666867
-
2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: The task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)
-
P.M. Elliott, A. Anastasakis, M.A. Borger, M. Borggrefe, F. Cecchi, P. Charron, A.A. Hagege, A. Lafont, G. Limongelli, H. Mahrholdt, W.J. McKenna, J. Mogensen, P. Nihoyannopoulos, S. Nistri, P.G. Pieper, B. Pieske, C. Rapezzi, F.H. Rutten, C. Tillmanns, and H. Watkins 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC) Eur Heart J 35 2014 2733 2779
-
(2014)
Eur Heart J
, vol.35
, pp. 2733-2779
-
-
Elliott, P.M.1
Anastasakis, A.2
Borger, M.A.3
Borggrefe, M.4
Cecchi, F.5
Charron, P.6
Hagege, A.A.7
Lafont, A.8
Limongelli, G.9
Mahrholdt, H.10
McKenna, W.J.11
Mogensen, J.12
Nihoyannopoulos, P.13
Nistri, S.14
Pieper, P.G.15
Pieske, B.16
Rapezzi, C.17
Rutten, F.H.18
Tillmanns, C.19
Watkins, H.20
more..
-
18
-
-
84877579357
-
Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): A report of the American College of Cardiology/American Heart Association task force on practice guidelines
-
L.S. Wann, A.B. Curtis, K.A. Ellenbogen, N.A. Estes, M.D. Ezekowitz, W.M. Jackman, C.T. January, J.E. Lowe, R.L. Page, D.J. Slotwiner, W.G. Stevenson, C.M. Tracy, V. Fuster, L.E. Ryden, D.S. Cannom, H.J. Crijns, J.L. Halperin, J. Le Heuzey, G.N. Kay, S.B. Olsson, E.N. Prystowsky, and J.L. Tamargo Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association task force on practice guidelines Circulation 127 2013 1916 1926
-
(2013)
Circulation
, vol.127
, pp. 1916-1926
-
-
Wann, L.S.1
Curtis, A.B.2
Ellenbogen, K.A.3
Estes, N.A.4
Ezekowitz, M.D.5
Jackman, W.M.6
January, C.T.7
Lowe, J.E.8
Page, R.L.9
Slotwiner, D.J.10
Stevenson, W.G.11
Tracy, C.M.12
Fuster, V.13
Ryden, L.E.14
Cannom, D.S.15
Crijns, H.J.16
Halperin, J.L.17
Le Heuzey, J.18
Kay, G.N.19
Olsson, S.B.20
Prystowsky, E.N.21
Tamargo, J.L.22
more..
-
19
-
-
77955303165
-
Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy
-
C.Y. Ho, B. Lopez, O.R. Coelho-Filho, N.K. Lakdawala, A.L. Cirino, P. Jarolim, R. Kwong, A. Gonzalez, S.D. Colan, J.G. Seidman, J. Diez, and C.E. Seidman Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy N Engl J Med 363 2010 552 563
-
(2010)
N Engl J Med
, vol.363
, pp. 552-563
-
-
Ho, C.Y.1
Lopez, B.2
Coelho-Filho, O.R.3
Lakdawala, N.K.4
Cirino, A.L.5
Jarolim, P.6
Kwong, R.7
Gonzalez, A.8
Colan, S.D.9
Seidman, J.G.10
Diez, J.11
Seidman, C.E.12
-
20
-
-
33745448546
-
Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease
-
R.Y. Kwong, A.K. Chan, K.A. Brown, C.W. Chan, H.G. Reynolds, S. Tsang, and R.B. Davis Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease Circulation 113 2006 2733 2743
-
(2006)
Circulation
, vol.113
, pp. 2733-2743
-
-
Kwong, R.Y.1
Chan, A.K.2
Brown, K.A.3
Chan, C.W.4
Reynolds, H.G.5
Tsang, S.6
Davis, R.B.7
-
21
-
-
33750946166
-
Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy
-
R.G. Assomull, S.K. Prasad, J. Lyne, G. Smith, E.D. Burman, M. Khan, M.N. Sheppard, P.A. Poole-Wilson, and D.J. Pennell Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy J Am Coll Cardiol 48 2006 1977 1985
-
(2006)
J Am Coll Cardiol
, vol.48
, pp. 1977-1985
-
-
Assomull, R.G.1
Prasad, S.K.2
Lyne, J.3
Smith, G.4
Burman, E.D.5
Khan, M.6
Sheppard, M.N.7
Poole-Wilson, P.A.8
Pennell, D.J.9
-
22
-
-
80052311517
-
The extent of left ventricular scar quantified by late gadolinium enhancement MRI is associated with spontaneous ventricular arrhythmias in patients with coronary artery disease and implantable cardioverter-defibrillators
-
P.A. Scott, J.M. Morgan, N. Carroll, D.C. Murday, P.R. Roberts, C.R. Peebles, S.P. Harden, and N.P. Curzen The extent of left ventricular scar quantified by late gadolinium enhancement MRI is associated with spontaneous ventricular arrhythmias in patients with coronary artery disease and implantable cardioverter-defibrillators Circ Arrhythm Electrophysiol 4 2011 324 330
-
(2011)
Circ Arrhythm Electrophysiol
, vol.4
, pp. 324-330
-
-
Scott, P.A.1
Morgan, J.M.2
Carroll, N.3
Murday, D.C.4
Roberts, P.R.5
Peebles, C.R.6
Harden, S.P.7
Curzen, N.P.8
-
23
-
-
84920409668
-
Cerebrovascular involvement in Fabry disease: Current status of knowledge
-
E. Kolodny, A. Fellgiebel, M.J. Hilz, K. Sims, P. Caruso, T.G. Phan, J. Politei, R. Manara, and A. Burlina Cerebrovascular involvement in Fabry disease: current status of knowledge Stroke 46 2015 302 313
-
(2015)
Stroke
, vol.46
, pp. 302-313
-
-
Kolodny, E.1
Fellgiebel, A.2
Hilz, M.J.3
Sims, K.4
Caruso, P.5
Phan, T.G.6
Politei, J.7
Manara, R.8
Burlina, A.9
-
24
-
-
84872956926
-
Acute cerebrovascular disease in the young: The stroke in young Fabry patients study
-
A. Rolfs, F. Fazekas, U. Grittner, M. Dichgans, P. Martus, M. Holzhausen, T. Bottcher, P.U. Heuschmann, T. Tatlisumak, C. Tanislav, G.J. Jungehulsing, A.K. Giese, J. Putaala, R. Huber, U. Bodechtel, C. Lichy, C. Enzinger, R. Schmidt, M.G. Hennerici, M. Kaps, C. Kessler, K. Lackner, E. Paschke, W. Meyer, H. Mascher, O. Riess, E. Kolodny, and B. Norrving Acute cerebrovascular disease in the young: the stroke in young Fabry patients study Stroke 44 2013 340 349
-
(2013)
Stroke
, vol.44
, pp. 340-349
-
-
Rolfs, A.1
Fazekas, F.2
Grittner, U.3
Dichgans, M.4
Martus, P.5
Holzhausen, M.6
Bottcher, T.7
Heuschmann, P.U.8
Tatlisumak, T.9
Tanislav, C.10
Jungehulsing, G.J.11
Giese, A.K.12
Putaala, J.13
Huber, R.14
Bodechtel, U.15
Lichy, C.16
Enzinger, C.17
Schmidt, R.18
Hennerici, M.G.19
Kaps, M.20
Kessler, C.21
Lackner, K.22
Paschke, E.23
Meyer, W.24
Mascher, H.25
Riess, O.26
Kolodny, E.27
Norrving, B.28
more..
-
25
-
-
84897573302
-
Outcomes of patients treated through the Canadian Fabry disease initiative
-
S.M. Sirrs, D.G. Bichet, R. Casey, J.T. Clarke, K. Lemoine, S. Doucette, and M.L. West Outcomes of patients treated through the Canadian Fabry disease initiative Mol Genet Metab 111 2014 499 506
-
(2014)
Mol Genet Metab
, vol.111
, pp. 499-506
-
-
Sirrs, S.M.1
Bichet, D.G.2
Casey, R.3
Clarke, J.T.4
Lemoine, K.5
Doucette, S.6
West, M.L.7
|